Report cover image

Global Markets for Diabetes Therapeutics and Diagnostics

Publisher BCC Research
Published Jan 08, 2026
Length 187 Pages
SKU # WA20707830

Description

Report Scope

The report provides an overview of the global diabetes therapeutics and diagnostics market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented by product and end-user. The diabetes market by product is divided into three segments: diabetes therapeutics, diabetes monitoring devices and accessories, and insulin delivery devices. Diabetes therapeutics encompass injectable therapies, such as Glucagon-Like Peptide-1 (GLP-1) and insulin, as well as oral antidiabetic drugs (OADs). Diabetes monitoring devices are categorized into blood glucose test strips (BGTS), blood glucose meters, lancets and lancet devices, and continuous glucose monitoring (CGM) systems. Insulin delivery devices are further divided into insulin pumps, insulin pens and needles, insulin syringes, and other products. Based on end users, the market is segmented into hospitals and clinics, home care settings, and diagnostic centers. Geographical regions covered in this study are North America (the U.S., Canada and Mexico), Europe (Germany, the U.K., Italy, France, Spain and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

This study further focuses on the driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading global companies in diabetes therapeutics and diagnostics. It also contains a dedicated section of company profiles that covers companies’ overviews, key financials, product portfolios and recent developments.

Report Includes
  • 161 data tables and 72 additional tables
  • In-depth analysis of the global markets for diabetes therapeutics and diagnostics
  • Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
  • Estimates of the current market size and revenue prospects of the global market, along with a market share analysis by product type, end user and region
  • Facts and figures about market dynamics, opportunities and deterrents, technological advances, regulations, prospects and the impact of various macroeconomic variables
  • Insights derived from Porter’s Five Forces model, as well as global supply chain analysis
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • A relevant patent analysis, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares, strategic initiatives, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including Abbott, Dexcom, Novo Nordisk A/S, Eli Lilly and Co., and Sanofi


Companies Mentioned

ABBOTT
ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
B. BRAUN SE
DEXCOM INC.
EMBECTA CORP.
F. HOFFMANN-LA ROCHE LTD.
INSULET CORP.
LIFESCAN IP HOLDINGS LLC.
LILLY USA LLC.
MEDTRONIC
MERCK & CO. INC.
NOVO NORDISK A/S
SANOFI
TERUMO CORP.

Table of Contents

187 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Epidemiology of Diabetes
Regional Distribution
Gender Distribution
Porter's Five Forces Analysis
Potential for New Entrants (Low to Moderate)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (High)
Threat of Substitutes (Low)
Competition in the Industry (Low to Moderate)
Macroeconomic Factors Analysis
Healthcare Spending
Insurance Coverage and Reimbursement Policies
Technological Advances
The U.S. Tariff Scenario
Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Prevalence of Diabetes
Growing Geriatric Population
Changing Lifestyle Habits
Market Restraints
High Cost of Diabetes Care
Limited Healthcare Access in Low- and Middle-Income Countries
Market Opportunities
Integration of AI, IoT and Wearables for Remote Monitoring
Government Funding and Initiatives
Growing Public-Private Partnerships and Industry Collaborations
Market Challenges
Data Privacy and Cybersecurity Risks
Shortage of Skilled Professionals
Chapter 4 Regulatory Landscape
Regulatory Frameworks
U.S.
Europe
Other Regions
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Next-Generation Insulin Delivery Systems
Multi-GLP Agonist
Non-Invasive Glucose Monitoring
Artificial Intelligence
Analysis of Clinical Trials
Key Takeaways
Analysis of Clinical Trials by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Patent Analysis
Key Takeaways
Patents, by Year
Patents, by Leading Applicant
Patents, by Leading Patent Holder
Patents, by Jurisdiction
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Diabetes Therapeutics and Diagnostic Market, by Product
Key Takeaways
Diabetes Therapeutics
Diabetes Monitoring Devices and Accessories
Insulin Delivery Devices
Global Diabetes Therapeutics and Diagnostic Market, by End User
Key Takeaways
Home Care Setting
Hospitals and Clinics
Diagnostic Centers
Geographic Breakdown
Global Diabetes Therapeutics and Diagnostic Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Leading Companies
Novo Nordisk A/S
Lilly
Abbott
Dexcom
Medtronic
Embecta Corp.
Key Strategic Developments
Chapter 8 Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
Introduction to ESG
ESG in Diabetes Therapeutics and Diagnostics
Key ESG Issues
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
Chapter 9 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
B. BRAUN SE
DEXCOM INC.
EMBECTA CORP.
F. HOFFMANN-LA ROCHE LTD.
INSULET CORP.
LIFESCAN IP HOLDINGS LLC.
LILLY USA LLC.
MEDTRONIC
MERCK & CO. INC.
NOVO NORDISK A/S
SANOFI
TERUMO CORP.
Few Emerging Start-ups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us